Roadmaps to Regulation: Cannabis, Psychedelics, MDMA, and NPS

The work of organisations such as the Beckley Foundation has helped create more interest in alternative options to the current drug control paradigm than ever before. It is becoming increasingly clear that the ‘War on Drugs’ has failed, so Amanda Feilding undertook the present report to address the growing appetite for drug policy reform.

The Report will assess the harms related to four substance-types: cannabis, psychedelics, MDMA (‘Ecstasy’), and new psychoactive substances (NPS). It will formulate models of strict regulation based on the developing evidence-base, and propose methodological tools for assessing the benefits and harms of the different regulatory models, which could be adapted to different national realities.